These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 24373314

  • 1. Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.
    Krylov VN.
    Adv Virus Res; 2014; 88():227-78. PubMed ID: 24373314
    [Abstract] [Full Text] [Related]

  • 2. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, Shanahan F, Coffey A, Ross RP, Hill C.
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [Abstract] [Full Text] [Related]

  • 3. Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model.
    Beeton ML, Alves DR, Enright MC, Jenkins AT.
    Int J Antimicrob Agents; 2015 Aug; 46(2):196-200. PubMed ID: 26100212
    [Abstract] [Full Text] [Related]

  • 4. A genetic approach to the development of new therapeutic phages to fight pseudomonas aeruginosa in wound infections.
    Krylov V, Shaburova O, Krylov S, Pleteneva E.
    Viruses; 2012 Dec 21; 5(1):15-53. PubMed ID: 23344559
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.
    Hall AR, De Vos D, Friman VP, Pirnay JP, Buckling A.
    Appl Environ Microbiol; 2012 Aug 21; 78(16):5646-52. PubMed ID: 22660719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms.
    Pires D, Sillankorva S, Faustino A, Azeredo J.
    Res Microbiol; 2011 Oct 21; 162(8):798-806. PubMed ID: 21782936
    [Abstract] [Full Text] [Related]

  • 20. [Properties of the new D3-like Pseudomonas aeruginosa bacteriophage phiPMG1: genome structure and prospects for the use in phage therapy].
    Krylov SV, Kropinski AM, Pleteneva EA, Shaburova OV, Burkal'tseva MV, Miroshnikov KA, Krylov VN.
    Genetika; 2012 Sep 21; 48(9):1057-67. PubMed ID: 23113333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.